Compass Therapeutics LLC — Form D

Compass Therapeutics LLC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-01-08. The offering totals $50.0M, of which $21.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
ERRIK J ANDERSONDirectorCAMBRIDGE, MA
BEN J AUSPITZDirectorCAMBRIDGE, MA
WILL J EDENDirectorCAMBRIDGE, MA
PHILIP J FERNEAUDirectorCAMBRIDGE, MA
CARL J GORDONDirectorCAMBRIDGE, MA
THOMAS J SCHUETZDirectorCAMBRIDGE, MA
STEVEN J SQUINTODirectorCAMBRIDGE, MA
BRUCE J STEELDirectorCAMBRIDGE, MA
STEVE J TREGAYDirectorCAMBRIDGE, MA
DAMON J BANKSExecutive OfficerCAMBRIDGE, MA
VERED J BISKER-LEIBExecutive OfficerCAMBRIDGE, MA
PIOTR J BOBROWICZExecutive OfficerCAMBRIDGE, MA
JEB J LEDELLExecutive OfficerCAMBRIDGE, MA
SARA J MANNLEExecutive OfficerCAMBRIDGE, MA
THOMAS J SCHUETZExecutive OfficerCAMBRIDGE, MA
ERRIK J ANDERSONPromoterCAMBRIDGE, MA
THOMAS J SCHUETZPromoterCAMBRIDGE, MA
CARL GORDONDirectorSAN DIEGO, CA
Stephen SquintoDirectorStamford, CT
Errik AndersonDirectorCambridge, MA
Errik AndersonExecutive OfficerCambridge, MA
Errik AndersonPromoterCambridge, MA
Steve TregayDirectorSan Carlos, CA
Ben AuspitzDirectorCambridge, MA
Philip FerneauDirectorHanover, NH

Other filings by this issuer (5)

FiledFormOfferingSold
2018-07-16D/A$170.2M$110.2M
2016-09-21D/A$170.2M$46.0M
2015-07-01D$121.0M$16.0M
2015-05-28D/A$1.0M$575K
2014-06-13D$1.0M$475K

More